PAM
ASND icon

Panagora Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Panagora Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,503
Closed -$27K – 2304
2015
Q3 		$27K Sell
1,503
-761
-34% -$14.8K ﹤0.01% 2095
2015
Q2 		$40K Buy
+2,264
New +$39.6K ﹤0.01% 2191

Other funds holding ASND

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Panagora Asset Management's ASND Position: Q4 2015 in Review

Panagora Asset Management sold out of Ascendis Pharma A/S (ASND) in Q4 2015, closing a stake of 1,503 shares — an estimated $27K sold.

Panagora Asset Management first reported a position in ASND in Q2 2015 and held it in 2 quarters. The position peaked at $40K in Q2 2015. 25 funds tracked by Wall St. Rank hold ASND as of Q4 2015.

  • Panagora Asset Management reported no remaining Ascendis Pharma A/S position as of Q4 2015 after selling out during the quarter.
  • Panagora Asset Management sold 1,503 Ascendis Pharma A/S shares in Q4 2015, an estimated $27K.
  • Panagora Asset Management first reported a position in Ascendis Pharma A/S in Q2 2015 and held it in 2 quarters.
  • Panagora Asset Management's Ascendis Pharma A/S position peaked at $40K in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2015.

Based on Panagora Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.